α-L-Iduronidase and enzyme replacement therapy for mucopolysaccharidosis I

ISSN： 1471-2598

Source： Expert Opinion on Biological Therapy, Vol.2, Iss.8, 2002-12, pp. : 967-976

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Glycosidase active site mutations in human α-L-iduronidase

By Eslahpazire J.

Glycobiology, Vol. 11, Iss. 9, 2001-09 ,pp. : 741-750

Oxford University Press

Access to resources Recommend Favorite

Plasmatic kinetics of dermatan sulfate during enzyme replacement therapy with iduronate-2-sulfatase in a mucopolysaccharidosis II Patient

By Volpi Nicola Zampini Lucia Maccari Francesca Santoro Lucia Galeotti Fabio Galeazzi Tiziana Gabrielli Orazio Coppa Giovanni

Glycoconjugate Journal, Vol. 30, Iss. 7, 2013-10 ,pp. : 727-732

Springer Publishing Company

Access to resources Recommend Favorite

Production in yeast of α -galactosidase A, a lysosomal enzyme applicable to enzyme replacement therapy for Fabry disease

By Chiba Yasunori

Glycobiology, Vol. 12, Iss. 12, 2002-12 ,pp. : 821-828

Oxford University Press

Access to resources Recommend Favorite

Enzyme Replacement Therapy of Fabry Disease

By Clarke Joe T. R. Iwanochko R. Mark

Molecular Neurobiology, Vol. 32, Iss. 1, 2005-08 ,pp. : 43-50

Humana Press, Inc

Access to resources Recommend Favorite

Enzyme replacement therapy for Gaucher disease

By Charrow Joel

Expert Opinion on Biological Therapy, Vol. 9, Iss. 1, 2009-01 ,pp. : 121-131

Informa Healthcare

Access to resources Recommend Favorite